STING1 and neoplasm: For example, in a preclinical study, Le et al., 2023, used FDG PET to visualize systemic effects, stimulated by STING agonist-induced lymphocytes in KPC tumor bearing mice and found an increased uptake of 18F-FDG in secondary lymph nodes (29).